Announcing the launch of Breakthroughs Today, Cures Tomorrow, our 20th anniversary campaign! 

Search

Category: Blog

Blog

Research Spotlight: Rodney Hicks, MD

Peptide receptor radionuclide therapy, or PRRT, has been available as a treatment option for some forms of neuroendocrine tumors – particularly for those NETs expressing the somatostatin receptor-2 (SSTR2) protein.

Read More »
Blog

Research Spotlight: Po Hien Ear, PhD

Dr. Po Hien Ear’s research involves growing NET spheroid clusters in large enough numbers to be used to screen the potential anti-tumor properties of hundreds of therapeutic compounds.

Read More »
Blog

Join the eNET Study!

Doctors at University of California San Francisco (UCSF) are conducting the first-of-its-kind e-NET study to learn about symptoms and quality of life for patients with neuroendocrine cancer. This is your chance to become a citizen scientist and help the researchers learn more about NETs.

Read More »